Skip to main content
. Author manuscript; available in PMC: 2013 Jun 14.
Published in final edited form as: Clin Cancer Res. 2012 Jun 25;18(16):4406–4414. doi: 10.1158/1078-0432.CCR-12-0357

Table 2.

EGFR gene mutations identified

Exon Amino acid change Frequency no. (%)a
EGFR-TKI Chemo
18 G719Ab 2 (2) 2 (4)
G719Cc 2 (2) 1 (2)
G719S 1 (1) 0 (0)
E709Kd 1 (1) 0 (0)
19 dele 48 (48) 25 (46)
delinsf 8 (8) 8 (15)
K754Ee 1 (1) 0 (0)
I740Tf 1 (1) 0 (0)
A755Df 1 (1) 0 (0)
D761Yc 1 (1) 0 (0)
20 T790Mg 4 (4) 4 (7)
S768Ic 1 (1) 1 (2)
G779Cb 1 (1) 0 (0)
21 L858Rd 34 (34) 18 (33)
L861Qb,e,h 8 (8) 0 (0)
R776Se 1 (1) 0 (0)
V834Ld 1 (1) 0 (0)
G873Ee 1 (1) 0 (0)
22 M881Th 1 (1) 0 (0)

Abbreviations: del, deletion; delins, deletion-insertion.

a

Twenty-one patients had more than one EGFR mutation, including one patient with 3 mutations.

b

One patient had both G719A and G779C; one patient had both G719A and L861Q.

c

One patient had both G719C and D761Y; two patients had both G719C and S768I.

d

One patient had both L858R and E709K; one patient had both L858R and V834L.

e

One patient had both exon 19 del and K754E; one patient had both exon 19 del and R776S; one patient had all of G873E, L861Q, and exon 19 del.

f

One patient had both exon 19 delins and I740T; one patient had both an exon 19 delins and A755D.

g

All 8 patients with T790M had concurrent sensitizing EGFR mutations (3 patients with exon 19 del; 2 patients with exon 19 delins; 3 patients with L858R).

h

One patient had both L861Q and M881T.